Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 19,751,284 | 19,751,284 | 0 | $771.68M | $932.26M | 33.31% | +$160.58M |
| Kymera Therapeutics, Inc.(KYMR) | 5,161,801 | 5,502,710 | +340,909 | $141.28M | $240.14M | 8.58% | +$98.86M |
| Revolution Medicines, Inc.(RVMD) | 4,982,384 | 4,982,384 | 0 | $176.18M | $183.30M | 6.55% | +$7.12M |
| Protagonist Therapeutics Inc | 2,575,015 | 3,211,041 | +636,026 | $124.53M | $177.47M | 6.34% | +$52.95M |
| Axsome Therapeutics, Inc.(AXSM) | 1,690,221 | 1,690,221 | 0 | $197.13M | $176.44M | 6.30% | -$20.69M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 2,796,513 | 2,761,333 | -35,180 | $125.98M | $140.52M | 5.02% | +$14.54M |
| GH Research PLC(GHRS) | 8,827,712 | 8,827,712 | 0 | $97.37M | $107.61M | 3.84% | +$10.24M |
| Ionis Pharmaceuticals, Inc.(IONS) | 1,913,385 | 1,913,385 | 0 | $57.73M | $75.60M | 2.70% | +$17.87M |
| Xoma Royalty Corporation | 2,983,026 | 2,590,303 | -392,723 | $59.45M | $65.28M | 2.33% | +$5.82M |
| Zymeworks Inc.(ZYME) | 4,308,935 | 4,308,935 | 0 | $51.32M | $54.08M | 1.93% | +$2.76M |
| Septerna, Inc.(SEPN) | 4,396,124 | 4,396,124 | 0 | $25.45M | $46.47M | 1.66% | +$21.01M |
| Celcuity Inc.(CELC) | 3,466,000 | 3,466,000 | 0 | $35.04M | $46.27M | 1.65% | +$11.23M |
| Kura Oncology, Inc.(KURA) | 7,754,129 | 7,754,129 | 0 | $51.18M | $44.74M | 1.60% | -$6.44M |
| Cullinan Therapeutics, Inc.(CGEM) | 5,750,683 | 5,750,683 | 0 | $43.53M | $43.30M | 1.55% | -$230.0K |
| AC Immune SASHS(ACIU) | 19,822,436 | 19,822,436 | 0 | $37.07M | $40.24M | 1.44% | +$3.17M |
| Cidara Therapeutics Inc | 924,642 | 786,392 | -138,250 | $19.92M | $38.31M | 1.37% | +$18.39M |
| Tyra Biosciences, Inc.(TYRA) | 3,944,194 | 3,944,194 | 0 | $36.68M | $37.75M | 1.35% | +$1.06M |
| Structure Therapeutics IncADS | 1,771,417 | 1,771,417 | 0 | $30.66M | $36.74M | 1.31% | +$6.08M |
| Immunocore Holdings plcADS(IMCR) | 0 | 1,024,288 | +1,024,288 | $0 | $32.14M | 1.15% | +$32.14M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 5,660,132 | 5,660,132 | 0 | $26.26M | $25.53M | 0.91% | -$735.8K |
| Foghorn Therapeutics Inc.(FHTX) | 5,302,000 | 5,302,000 | 0 | $19.35M | $24.92M | 0.89% | +$5.57M |
| Olema Pharmaceuticals, Inc.(OLMA) | 5,295,893 | 5,295,893 | 0 | $19.91M | $22.56M | 0.81% | +$2.65M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 1,387,863 | +1,387,863 | $0 | $22.40M | 0.80% | +$22.40M |
| Xencor, Inc.(XNCR) | 2,740,141 | 2,740,141 | 0 | $29.16M | $21.54M | 0.77% | -$7.62M |
| 4d Molecular Therapeutics In | 4,561,289 | 4,629,289 | +68,000 | $14.73M | $17.17M | 0.61% | +$2.44M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 6,293,282 | 6,293,282 | 0 | $21.33M | $17.05M | 0.61% | -$4.28M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $13.51M | $16.80M | 0.60% | +$3.29M |
| Palvella Therapeutics, Inc.(PVLA) | 696,555 | 696,555 | 0 | $19.50M | $15.70M | 0.56% | -$3.80M |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $13.82M | $14.87M | 0.53% | +$1.05M |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $10.19M | $14.36M | 0.51% | +$4.18M |
| Verastem, Inc.(VSTM) | 2,100,468 | 3,404,425 | +1,303,957 | $12.67M | $14.13M | 0.50% | +$1.46M |
| Rapt Therapeutics Inc | 0 | 1,154,692 | +1,154,692 | $0 | $9.24M | 0.33% | +$9.24M |
| Forte Biosciences Inc | 594,282 | 588,344 | -5,938 | $4.61M | $7.61M | 0.27% | +$3.00M |
| TScan Therapeutics, Inc.(TCRX) | 4,889,474 | 5,226,074 | +336,600 | $6.75M | $7.58M | 0.27% | +$830.3K |
| Ikena Oncology Inc | 4,006,564 | 4,006,564 | 0 | $5.13M | $5.37M | 0.19% | +$240.4K |
| Immunic, Inc.(IMUX) | 8,902,972 | 7,652,972 | -1,250,000 | $9.70M | $5.34M | 0.19% | -$4.37M |
| Molecular Partners AGADS(MOLN) | 1,353,968 | 1,353,968 | 0 | $5.51M | $5.19M | 0.19% | -$325.0K |
| Avalo Therapeutics, Inc.(AVTX) | 1,036,679 | 1,028,049 | -8,630 | $8.30M | $5.13M | 0.18% | -$3.17M |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $2.06M | $2.14M | 0.08% | +$82.3K |
| Tenax Therapeutics, Inc.(TENX) | 339,549 | 339,549 | 0 | $2.22M | $1.98M | 0.07% | -$241.1K |
| SAB Biotherapeutics, Inc.(SABS) | 917,826 | 917,826 | 0 | $1.24M | $1.61M | 0.06% | +$367.1K |
| Ovid Therapeutics Inc.(OVID) | 3,853,818 | 3,853,818 | 0 | $1.20M | $1.27M | 0.05% | +$69.4K |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $605.1K | $586.1K | 0.02% | -$18.9K |
| Nls Pharmaceutics Ltd | 143,676 | 143,676 | 0 | $221.3K | $416.7K | 0.01% | +$195.4K |
| Allakos Inc | 16,552,417 | 0 | -16,552,417 | $3.77M | $0 | — | -$3.77M |
| CytomX Therapeutics, Inc.(CTMX) | 5,228,461 | 0 | -5,228,461 | $3.32M | $0 | — | -$3.32M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,454,422 | 0 | -1,454,422 | $36.54M | $0 | — | -$36.54M |
| Glycomimetics Inc | 9,544,262 | 0 | -9,544,262 | $2.00M | $0 | — | -$2.00M |
| Iteos Therapeutics Inc | 3,075,000 | 0 | -3,075,000 | $18.36M | $0 | — | -$18.36M |
| Newamsterdam Pharma Company ORDINARY SHARES | 59,065 | 0 | -59,065 | $1.21M | $0 | — | -$1.21M |
| Rapt Therapeutics Inc | 9,237,556 | 0 | -9,237,556 | $11.27M | $0 | — | -$11.27M |
| Third Harmonic Bio Inc | 2,372,933 | 0 | -2,372,933 | $8.23M | $0 | — | -$8.23M |
| Verve Therapeutics Inc | 6,904,050 | 0 | -6,904,050 | $31.55M | $0 | — | -$31.55M |
| Vigil Neuroscience Inc | 4,013,633 | 0 | -4,013,633 | $7.14M | $0 | — | -$7.14M |